Drug therapy of allergic rhinitis in children
https://doi.org/10.21518/2079-701X-2013-2-66-70
Abstract
About the Authors
E. P. KarpovaRussian Federation
D. A. Tulupov
Russian Federation
References
1. World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA). 2008. Update. (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)// Allergy. 2008.№ 63(86). P.8–160.
2. Ильина Н.И. Эпидемиология аллергического ринита // Российская ринология. 1999. №1. С.23-25.
3. Canonica G.W., Passalacqua G., Baiardini I., Senna G. Adherence to pharmacological treatment and specific immu-notherapy in allergic rhinitis. // Clin Exp Allergy. 2013. №43(1). P.22-28.
4. Kern R. Allergy: a constant factor in the etiology of so-called mucous nasal polyps. J Allergy. 1993. №4. P.483.
5. Caffarelli C., Savini E., Giordano S., Gianlupi G., Cavagni G. Atopy in children with otitis media with effusion. Clin Exp Allergy. 1998. 28(5). P.591-596.
6. Aberg N., Sundell J., Eriksson B., Hesselmar B., Aberg B. Prevalence of allergic diseases in school children in relation to family history, upper respiratory infections, and residential characteristics. Allergy. 1996. №51(4). P.232–237.
7. Tran N.P., Vickery J., Blaiss M.S. Management of Rhinitis: Allergic and Non-Allergic. Allergy Asthma Immunol Res. 2011. № 3(3). P.148-156.
8. Okubo K., Kurono Y., Fujieda S., Ogino S., Uchio E., Odajima H., Takenaka H., Baba K. Japanese Guideline for Allergic Rhinitis. Allergology International. 2011. №60. P.171-189.
9. European position paper on rhinosinusitis and nasal polyps 2012 (EP3OS). Rhinology. 2012. №50(23). P. 1-299.
10. Карпова Е. П. Лечение аллергического ринита у детей (руководство для врачей). М.: Гэотар-медиа, 2007.
11. Ревякина В.А. Антигистаминные препараты в клинической практике. Дискуссионные вопросы. Взгляд врача на привычные препараты. Лечащий врач. 2010; №7. С.71-73.
12. Brozek J.L., Bousquet J., Baena-Cagnani C.E., Bonini S., Canonica G.W., Casale T.B., van Wijk R.G., Ohta K., Zuberbier T., Schünemann H.J.; Global Allergy and Asthma European Network; Grading of Recommendations Assessment, Development and Evaluation Working Group. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010. №126(3). P.466-476.
13. Карпова Е.П., Тулупов Д.А. Назальные сосудосуживающие препараты в педиатрической практике. Эффективная фармакотерапия. Педиатрия. 2012. № 1. С.18-24.
14. Карпова Е.П., Соколова М.В., Антонова Н.В. Особенности терапии аллергического ринита у детей. Вестник оториноларингологии. 2009. №2. С.36-39.
15. Marchisio P., Varricchio A., Baggi E., Bianchini S., Capasso M.E., Torretta S., Capaccio P., Gasparini C., Patria F., Esposito S., Principi N. Hypertonic saline is more effective than normal saline in seasonal allergic rhinitis in chil-dren. Int J Immunopathol Pharmacol. 2012. №25(3). P.721-730.
16. Wolthers O.D. Relevance of pharmacokinetics and bioavailability of intranasal corticosteroids in allergic rhinitis. Recent Pat Inflamm Allergy Drug Discov. 2010. №4(2). P.118-123.
17. Sastre J., Mosges R. Local and Systemic Safety of Intranasal Corticosteroids. J Investig Allergol Clin Immunol 2012. №22(1). P.1-12.
18. Bielory L., Friedlaender M.H. Allergic conjunctivitis. Immunol Allergy Clin North Am. 2008. №28(1). P.43-58.
19. Zhang L., Mendoza-Sassi R.A., César J.A., Chadha N.K. Intranasal corticosteroids for nasal airway obstruction in chil-dren with moderate to severe adenoidal hypertrophy. Cochrane Database Syst Rev. 2008. №16(3):CD006286.
20. Cengel S., Akyol M.U. The role of topical nasal steroids in the treatment of children with otitis media with effusion and/or adenoid hypertrophy. Int J Pediatr Otorhinolaryngol. 2006. №70(4). P. 639-645.
Review
For citations:
Karpova EP, Tulupov DA. Drug therapy of allergic rhinitis in children. Meditsinskiy sovet = Medical Council. 2013;(2):66-70. (In Russ.) https://doi.org/10.21518/2079-701X-2013-2-66-70